Anti-HMGCR Myopathy: A Rare and Serious Side Effect of Statins

References

1. 1.↵
   1. Selva-O'Callaghan A,
   2. Alvarado-Cardenas M,
   3. Pinal-Fernández I,
   4. et al

   . Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol 2018;14:215–24.

   OpenUrlCrossRef
2. 2.↵
   1. Pinal-Fernandez I,
   2. Casal-Dominguez M,
   3. Mammen AL

   . Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 2018;20:21.

   OpenUrl
3. 3.↵
   1. Carvalho AAS,
   2. Silva VGD,
   3. Vieira TF,
   4. et al

   . Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Medicine (Baltimore) 2018;97:e11858.

   OpenUrl
4. 4.↵
   1. Tournadre A

   . Statins, myalgia, and rhabdomyolysis. Joint Bone Spine 2019;87:37–42.

   OpenUrl
5. 5.↵
   1. Adler BL,
   2. Christopher-Stine L

   . Triggers of inflammatory myopathy: insights into pathogenesis. Discov Med 2018;25:75–83.

   OpenUrl
6. 6.↵
   1. Upreti S,
   2. Fayyaz B,
   3. Bongu RP

   . Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report. J Community Hosp Intern Med Perspect 2019;9:33–5.

   OpenUrl
7. 7.↵
   1. Ayesha SM,
   2. Meena AK,
   3. Vangala N,
   4. et al

   . Necrotizing autoimmune myopathy: clinicopathologic study from a single tertiary care centre. Ann Indian Acad Neurol 2018;21:62–7.

   OpenUrl
8. 8.↵
   1. Limaye V,
   2. Bundell C,
   3. Hollingsworth P,
   4. et al

   . Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve 2015;52:196–203.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Mohassel P,
   2. Mammen AL

   . Anti-HMGCR myopathy. J Neuromuscul Dis 2018;5:11–20.

   OpenUrl
10. 10.↵
    1. Basharat P,
    2. Lahouti AH,
    3. Paik JJ,
    4. et al

    . Statin-induced anti-HMGCR-associated myopathy. J Am Coll Cardiol 2016;68:234–5.

    OpenUrlFREE Full Text
11. 11.↵
    1. Allenbach Y,
    2. Mammen AL,
    3. Benveniste O,
    4. et al

    . Immune-mediated necrotizing myopathies working G. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromusc Disord 2018;28:87–99.

    OpenUrl
12. 12.↵
    1. Palterer B,
    2. Vitiello G,
    3. Carraresi A,
    4. Giudizi MG,
    5. Cammelli D,
    6. Parronchi P

    . Bench to bedside review of myositis autoantibodies. Clin Mol Allergy 2018;16:5.

    OpenUrl
13. 13.↵
    1. Christopher-Stine L,
    2. Casciola-Rosen LA,
    3. Hong G,
    4. Chung T,
    5. Corse AM,
    6. Mammen AA

    . Novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010;62:2757–66.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Mammen AL,
    2. Chung T,
    3. Christopher-Stine L,
    4. et al

    . Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713–21.

    OpenUrlCrossRefPubMed